Rapid Micro Biosystems, Inc. Class A RPID 深 沪
已收盘 05-29 16:00:00 美东时间
2.01
-0.010
-0.50%
华盛通- 最 高2.09
- 今 开2.04
- 成交量 8.15万股
- 最 低 1.9601
- 昨 收 2.02
- 总市值 9933.35万
- 52周最高 4.94
- 市盈率 静 --
- 换手率 0.16%
- 52周最低 1.86
- 委 比 31.59%
- 总股本 4941.96万
- 历史最高 27.04
- 量 比 0.55
- 振 幅 6.43%
- 历史最低 0.58
- 每 手 1
- 风险率 0.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Keybanc Maintains Overweight on Rapid Micro Biosystems, Lowers Price Target to $5
Keybanc analyst Paul Knight maintains Rapid Micro Biosystems (NASDAQ:RPID) with a Overweight and lowers the price target from $8 to $5.
05-29 23:49
Lake Street Maintains Buy on Rapid Micro Biosystems, Lowers Price Target to $7
Lake Street analyst Thomas Flaten maintains Rapid Micro Biosystems (NASDAQ:RPID) with a Buy and lowers the price target from $8 to $7.
05-22 23:02
Rapid Micro Biosystems Q1 2026 Earnings Call: Complete Transcript
Rapid Micro Biosystems (NASDAQ:RPID) released first-quarter financial results a...
05-14 05:31
Rapid Micro Biosystems Affirms FY2026 Sales Guidance of $37.000M-$41.000M vs $39.225M Est
Rapid Micro Biosystems (NASDAQ:RPID) affirms FY2026 sales outlook from $37.000 million-$41.000 million to $37.000 million-$41.000 million vs $39.225 million estimate.
05-14 04:34
Rapid Micro Biosystems Q1 EPS $(0.31) Misses $(0.23) Estimate, Sales $8.002M Beat $7.600M Estimate
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.23) by 34.78 percent. This is a 19.23 percent decrease over losses of $(0.26) per
05-14 04:33
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
Rapid Micro Biosystems shares are trading lower after the company reported worse-than-expected Q4 financial results and issued FY26 sales guidance with its midpoint below estimates.
Rapid Micro Biosystems shares are trading lower after the company reported wors...
03-12 21:25
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
Rapid Micro Biosystems Sees FY2026 Sales $37.000M-$41.000M vs $40.125M Est
Rapid Micro Biosystems (NASDAQ:RPID) sees FY2026 sales of $37.000 million-$41.000 million vs $40.125 million analyst estimate.
03-12 19:06
Rapid Micro Biosystems Expects Q4 Revenue Of ~$11.3M, FY25 Revenue Of ~$33.6M
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release
01-14 05:16
